77 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
8 May 24
Maravai Lifesciences Reports First Quarter 2024 Financial Results
4:09pm
Quarter 2024
Three Months Ended March 31,
(Dollars in 000’s)
Year-over-Year % Change
Nucleic Acid Production
Biologics Safety Testing
Total Revenue … that did not repeat in the current quarter.
Biologics Safety Testing revenue was $18.2 million for the first quarter, representing a 3% increase year
8-K
EX-99.1
jbc5dzhiyt15 fro2
22 Feb 24
Maravai Lifesciences Reports Fourth Quarter and Full Year 2023 Financial Results
4:08pm
8-K
EX-99.1
zh3u9g0dg qrob9x
7 Nov 23
Maravai Lifesciences Reports Third Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
wwd4mx 431a6ff
7 Aug 23
Maravai Lifesciences Reports Second Quarter 2023 Financial Results
4:19pm
8-K
hopvgsr d5u1j
27 Jul 23
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
4:11pm
8-K
EX-99.1
4zyuro3d4 pda
27 Jul 23
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
4:11pm
8-K
EX-99.1
hs7i59m 7lc7pbw1n0
20 Jul 23
Maravai LifeSciences Announces Appointment of New Director to the Board
4:08pm
8-K
EX-99.1
bwp wt6yxzsb8r
8 May 23
Maravai Lifesciences Reports First Quarter 2023 Financial Results
4:09pm
8-K
EX-99.1
zahg1
1 Dec 22
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
4:26pm
8-K
4izg434evss7wkry
1 Dec 22
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
4:26pm